Competing effects of intravenously infused dilator agents and raised portal blood flow on hepatic arterial conductance.
d'Almeida
M S
MS
Department of Pharmacology & Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
McQuaker
J E
JE
D'Aleo
L M
LM
Lautt
W W
WW
D000818:Animals; D002415:Cats; D005263:Femoral Artery / Q000187:drug effects / Q000502:physiology; D005934:Glucagon / Q000494:pharmacology*; D006499:Hepatic Artery / Q000187:drug effects / Q000502:physiology*; D008638:Mesenteric Arteries / Q000187:drug effects / Q000502:physiology; D011169:Portal Vein / Q000187:drug effects / Q000502:physiology; D012016:Reference Values; D012079:Renal Circulation / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology*
D014665:Vasodilator Agents; D005934:Glucagon